Theorem Clinical Research

Global News

NIH-led effort launches Big Data portal for Alzheimer’s drug discovery

Friday, March 6, 2015 12:16 PM

A NIH-led public-private partnership to transform and accelerate drug development has launched a new Alzheimer’s Big Data portal—including delivery of the first wave of data—for use by the research community. The new data sharing and analysis resource is part of the Accelerating Medicines Partnership (AMP), an unprecedented venture bringing together NIH, FDA, industry and academic scientists from a variety of disciplines to translate knowledge faster and more successfully into new therapies.

More... »

Quest Diagnostics

Mallinckrodt Pharmaceuticals to acquire Ikaria

Friday, March 6, 2015 12:14 PM

Mallinckrodt, a global specialty biopharmaceutical company based in Dublin, through a subsidiary, will acquire Hampton, N.J.-based Ikaria, a privately held critical care company, from a Madison Dearborn-led investor group, in a transaction valued at approximately $2.3 billion.

More... »

The Bill & Melinda Gates Foundation, CureVac collaborate

Friday, March 6, 2015 12:11 PM

The Bill & Melinda Gates Foundation has made a commitment to invest $52 million in CureVac, a Germany-based, clinical-stage biopharmaceutical company specializing in mRNA-based vaccine technologies.

More... »

FDA expands approved use of Opdivo to treat lung cancer

Thursday, March 5, 2015 01:42 PM

The FDA has expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.

More... »

AbbVie to acquire Pharmacyclics for $21B, boosting hematological oncology franchise

Thursday, March 5, 2015 12:38 PM

AbbVie has announced a definitive agreement to acquire Pharmacyclics and its flagship asset Imbruvica (ibrutinib), a treatment for hematologic malignancies. 

More... »

Altasciences, ITR Laboratories form alliance

Thursday, March 5, 2015 12:36 PM

Altasciences, a Canada-based provider of early phase clinical research services, and ITR Laboratories, a nonclinical CRO, have formed a strategic alliance to offer clients a way to customize their drug development programs from lead candidate selection through to early stage clinical trials. This alliance facilitates working with a single integrated partner to bring drug candidates to proof-of-concept faster and reduce costs.

More... »

Baxter International acquires SuppreMol

Thursday, March 5, 2015 12:35 PM

Baxter International has acquired SuppreMol for approximately $225 million. SuppreMol is a privately held biopharmaceutical company based in Martinsried, Germany, developing treatment options for autoimmune and allergic diseases.

More... »

Techorizon launches electronic tool for feasibility study performance

Thursday, March 5, 2015 12:31 PM

Techorizon, a technology company based in Verona, Italy, with North American offices in Cambridge, Mass., has launched FeRMI, an electronic application for the conduct of clinical trial feasibility studies. Techorizon also launched a new web site.

More... »

Eisai, Merck collaborate on combination regimens for cancer

Thursday, March 5, 2015 12:29 PM

Eisai and Merck, through a subsidiary, have formed a clinical trial collaboration to evaluate the safety, tolerability and efficacy of Merck’s anti-PD-1 therapy, pembrolizumab (marketed in the U.S. under the brand name Keytruda), in combination with Eisai oncology compounds lenvatinib mesylate (a multi-targeting RTK inhibitor marketed in the U.S. under the brand name Lenvima, lenvatinib) and eribulin mesylate (a microtubule dynamics inhibitor marketed in nearly 60 countries including Japan, the U.S. and Europe under the brand name Halaven, eribulin) in multiple clinical trials.

More... »

AMRI hires VP of International Sales

Thursday, March 5, 2015 11:14 AM

Albany Molecular Research (AMRI), a global CRO based in Albany, N.Y., has hired Michael Pettersson to fill the newly created position of vice president of International Sales, effective immediately. He reports to Christopher Conway, senior vice president of Global Sales and Marketing.

More... »



March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs